Termination of Registration of a Class of Security Under Section 12(b) (15-12b)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number: 001-37521

 

INTEC PHARMA LTD.

(Exact name of registrant as specified in its charter)

 

12 Hartom Street

Har Hotzvim, Jerusalem 9777512

[phone]

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Ordinary Shares, no par value
Warrants to purchase Ordinary Shares

(Title of each class of securities covered by this Form)

 

N/A

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

Rule 12g-4(a)(1) ☒

Rule 12g-4(a)(2) ☐

Rule 12h-3(b)(1)(i) ☒

Rule 12h-3(b)(1)(ii) ☐

Rule 15d-6 ☐

Rule 15d-22(b) ☐

 

Approximate number of holders of record as of the certification or notice date: Ordinary Shares: One (1); Warrants to purchase Ordinary Shares: Thirty Two (32)

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Intec Pharma Ltd. has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: August 13, 2021	By:	/s/ Nir Sassi
		Nir Sassi
		Chief Financial Officer